![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 28, 2012 9:32:12 AM
QUOTE
FDA is responsible for protecting the public health by assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. UNQUOTE
So, both the FDA and Health Canada have safety and efficacy as the priorities - as they properly should. And they both cite devices.
To your post - I invested in BIEL because the ActiPatch worked a small miracle on a black & blue sprained ankle and I did not have to take the painkillers and anti-inlammatory drugs prescribed by my Doc. After 3 days of almost 24 hour ActiPatch, I went back to him, walking comfortably, most swelling gone. Tender? yes. Tentative? yes. But I was mobile and pretty comfortable. He couldn't believe it. It works!
Why did I go back to my Doc? To return the crutches - comments he made to me after the examination were were - "X-ray shows no break; you've got a very severe sprain, which is often more painful than a cracked or broken ankle; you'd better be prepared to be mostly off that ankle for 3 weeks to a month and here use these."
In my opinion, if BIEL does not get FDA approval ASAP, it is proof that the drug companies can influence decisions inappropriately, but I stress, I'm not a scientist. When BIEL does get its approval, it will be solid proof that the FDA is above the influences of the big drug companies and common sense prevailed. Pretty simple stuff.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM